ADVA Biotechnologies
Mrs. Amar has over 20 years of experience working in medical device companies, 15 years of which in the Quality arena. Mrs. Amar has an experience with ISO 13485 and MDSAP certifications and has vast knowledge in leading external and internal audits and working with global companies. Prior to joining ADVA Biotechnology Mrs. Amar worked as a QA Manager at ETView Ltd (Ambu A/S) where she managed the company activities concerning all quality aspects. Prior to ETView Sigal served at Plastmed as a QA Manager and collaborated with leading medical devices companies.
This person is not in any offices
ADVA Biotechnologies
ADVA Biotechnology develops enabling technologies for cell therapy manufacturing. The company has developed ADVA X3, a robust, modular cell-manufacturing cGMP system based on a single-use end-to-end solution.ADVA X3 enables autologous cell therapy manufacturing at the bedside, allowing optimization, tight quality assurance, improved availability,reduced time to market, and significant cost reduction. The automated platform is designed to enable autologous manufacturing of additional types of cells with a change in the disposable chamber, allowing efficiency and flexibility with a long pipeline of products.